Parental reporting of suspected adverse drug reactions in children in Lagos, Nigeria

Archives of Disease in Childhood

Volumn 94, Issue 6, 2009, Pages 469-473

  Oshikoya, Kazeem A ^a,b,c   Senbanjo, I O ^b   Njokanma, O F ^b  

^a LAGOS STATE UNIVERSITY   (Nigeria)

^b LAGOS STATE UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ARTEMETHER; ARTESUNATE; CHLOROQUINE; IBUPROFEN; PARACETAMOL; PYRIMETHAMINE; SALBUTAMOL; SULFADOXINE;

ARTICLE; CHILD; CHILD CARE; DIARRHEA; DRUG ERUPTION; HUMAN; NIGERIA; PARENTAL ATTITUDE; PHARMACY; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; CHILD, PRESCHOOL; COMMUNITY PHARMACY SERVICES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDICATION ERRORS; NIGERIA; PARENTS; PHARMACEUTICAL PREPARATIONS; PILOT PROJECTS; PRESCRIPTION DRUGS; QUESTIONNAIRES;

EID: 66749189372     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2008.152629     Document Type: Article

References (41)

1. Oshikoya KA, Njokanma OF, Chukwura HA, et al. Adverse drug reactions in Nigerian children. Paediatr Perinat Drug Ther 2007;8:81-88 (Pubitemid 47621487)
2. National Pharmacovigilance Centre (NPC), NAFDAC Nigeria. Safety of medicines in Nigeria: a guide for detecting and reporting adverse drug reactions. NAFDAC-NPC-NIG-2004-2011 Lagos: National Agency for Food and Drug Administration and Control, 2004.
3. Fehintola FA. Dipyrone: the ban, the justification (letter). Afr J Med Med Sci 2005;34:403-405
4. van Grootheest AC, van Puijenbroek EP, de Jong-van den Berg LTW. Contribution of pharmacists to the reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf 2002;11:205-210 (Pubitemid 34537526)
5. Morrison-Griffiths S, Walley TJ, Park BK, et al. Reporting of adverse drug reactions by nurses. Lancet 2003;361:1347-1348 (Pubitemid 36514869)
6. Blenkinsopp A, Wilkie P, Wang M. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 2006;63:148-156
7. van Grootheest AC, de Graaf L, de Jong-van den Berg LTW. Consumer adverse drug reaction reporting: a new step in pharmacovigilance? Drug Saf 2003;26:211-217
8. BMA. Reporting adverse drug reactions: a guide for healthcare professionals, 2006. Available from http://www.bma.org.uk/health-promotion- ethics/drugs-prescribing/ AdverseDrugReactions.jsp (accessed 11 February 2009).
9. Choonara I. Direct reporting of suspected adverse drug reactions by patients. J R Sci Med 2004;97:316-317 (Pubitemid 38918207)
10. de Langen J, van Hunsel F, Passier A, et al. Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf 2008;31:515-524
11. Egberts TCG, Smulders M, de Koning FHP, et al. Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals. BMJ 1996;313:530-531 (Pubitemid 26336138)
12. Hughes J, Gill A, Leach HJ, et al. A prospective study of adverse effects of midazolam on withdrawal in critically ill children. Acta Paediatr 1994;83:1194-1199 (Pubitemid 24348092)
13. Sharma R, Verma U, Sharma CL, et al. Self-medication among urban population of Jammu City. Indian J Pharmacol 2005;37:37-45. (Pubitemid 40239143)
14. Oshikoya KA, Njokanma OF, Bello JA, et al. The use of prescribed and nonprescribed drugs in infants in Lagos, Nigeria. J Med Sci 2008;8:111-117
15. Clarkson A, Conroy S, Burroughs K, et al. Surveillance for adverse drug reactions in children: a paediatric regional monitoring centre. Paediatr Perinat Drug Ther 2004;6:20-23 (Pubitemid 39107205)
16. Weiss J, Krebs S, Hoffmann C, et al. Survey of adverse drug reactions on a paediatric ward: a strategy for early and detailed detection. Paediatrics 2002;110:254-257 (Pubitemid 34833007)
17. Kidon MI, See Y. Adverse drug reactions in Singaporean children. Singapore Med J 2004;45:574-577 (Pubitemid 39643441)
18. Oshikoya KA, Chukwura HA, Ojo OI. Evaluation of outpatient paediatric drug prescription in a teaching hospital for rational prescribing. Paediatr Perinat Drug Ther 2006;7:183-188 (Pubitemid 46438576)
19. Ohaju-Obodo JO, Isah AO, Mabadeje AFB. Prescribing patterns of clinicians in private health institutions in Edo and Delta States of Nigeria. Niger Q J Hosp Med 1998;8:91-94
20. Odusanya OO, Oyediran MA. Rational drug use at the primary health care centres in Lagos, Nigeria. Niger Q J Hosp Med 2000;10:4-7.
21. Akinyede AA, Mabadeje AFB, Aliu MO. A comparative study of patterns of prescription of antibiotics in two health centres in Lagos. J Niger Infect Contr Assoc 2000;3:20-23
22. Oshikoya KA, Njokanma OF, Bello JA, et al. Family self-medication for children in an urban area of Nigeria. Paediatr Perinat Drug Ther 2007;8:124-130
23. Pharmacists Council of Nigeria. Code of ethics for pharmacists. Available at http://www.theconvention.org/regulations/ CODE%20OF%20ETHICS%20FOR%20PHARMACISTS%20IN%20NIGERIA.pdf (accessed 11 February 2009).
24. Stewart D, Helms P, McCaig D, et al. Monitoring adverse drug reactions in children using community pharmacies: a pilot study. Br J Clin Pharmacol 2005;59:677-683 (Pubitemid 40835501)
25. Arnod F, Choe MK, Roy TK. Son preference, the family-building process and child mortality in India. Popul Stud 1998;52:301-315 (Pubitemid 29026328)
26. Graham MJ, Larsen U, Xu X. Son preference in Anhui Province, China. Int Fam Plan Perspect 1998;24:72-77 (Pubitemid 128656615)
27. Larsen U, Chung W, Das Gupta M. Fertility and son preference in Korea. Popul Stud 1998;52:317-325
28. Choe MK, Hongseng H, Feng W. Effects of gender, birth order, and other correlates on childhood mortality in China. Soc Biol 1995;42:50-64.
29. Desgrées du Loû A, Pison G, Aaby P. Role of immunizations in the recent decline in childhood mortality and the changes in the female/male mortality ratio in rural Senegal. Am J Epidemiol 1995;142:643-652
30. Ashorn P, Maleta K, Espo M, et al. Male biased mortality among 1-2 year old children in rural Malawi. Arch Dis Child 2002;87:386-387 (Pubitemid 35252894)
31. Odusanya OO. The role of adjunct therapies in the treatment of uncomplicated malaria. Niger J Clin Pract 2002;5:32-36
32. Oshikoya KA. Antimalarial prescription for children presenting with uncomplicated malaria to a teaching hospital in Nigeria after the change of national guidelines for malaria treatment. World J Med Sci 2007;2:49-53.
33. Oshikoya KA, Senbanjo IO. Fever in children: mothers' perceptions and their home management. Iran J Pediatr 2008;18:229-236
34. Guillemot D, Carbon C, Balkau B, et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998;279:365-370 (Pubitemid 28133865)
35. Ezechukwu CC, Egbuonu I, Chikwuka JO. Drug treatment of common childhood symptoms in Nnewi: what mothers do? Niger J Clin Pract 2005;8:1-3.
36. van Grootheest AC, Passier JL, van Puijenbrock EP. Direct reporting of side effects by the patient: favourable experience in the first year. Ned Tijdschr Geneeskd 2005;149:529-533 (Pubitemid 40353565)
37. Jarernsiripornkul N, Krska J, Capps PAG, et al. Patient reporting of potential adverse drug reactions: a methodological study. Br J Clin Pharmacol 2002;53:318-325 (Pubitemid 34226975)
38. Jarernsiripornkul N, Krska J, Richards RM, et al. Patient reporting of adverse drug reactions: useful information for pain management? Eur J Pain 2003;7:219-224
39. Enwere OO, Fawole OI. Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug Saf 2008;17:517-522
40. Golomb B, Evans M. Risk factors for rhabdomyolysis with simvastatin and artovastatin. Drug Saf 2006;29:1191-1192 (Pubitemid 44904833)
41. Passier JLM, Srivastava N, van Puijenbroek EP. Isotretinoin-induced inflammatory bowel disease. Neth J Med 2006;64:52-54 (Pubitemid 43285588)